Literature DB >> 18704327

Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production.

Bahar Tunctan1, Fariborz A Yaghini, Anne Estes, Kafait U Malik.   

Abstract

Increased production of nitric oxide (NO) and prostaglandins contribute to development of hypotension during endotoxemia. We have previously demonstrated that endotoxemia-induced increase in NO production suppresses renal cytochrome P450 (CYP) 4A expression and activity, and that selective inhibition of inducible NO synthase (iNOS) with 1,3-PBIT restores renal CYP 4A protein and activity and mean arterial pressure (MAP). By using cyclooxygenase (COX) inhibitor indomethacin, we investigated herein whether prostaglandins, via NO production, inhibit renal CYP 4A1 protein expression and CYP 4A activity and contribute to the endotoxin-induced hypotension. In conscious male Sprague-Dawley rats, endotoxin (10 mg/kg, intraperitoneal (i.p.)) reduced MAP, increased serum nitrite and bicyclo PGE2 levels, renal nitrite production and iNOS protein expression, and decreased renal CYP 4A1 protein expression and CYP 4A activity after 4 h injection. All of the endotoxin-induced changes, except for increase in renal nitrite production, were prevented by indomethacin (5 mg/kg, i.p. 1 h after endotoxin). The effects of indomethacin on the endotoxin-induced decrease in MAP, CYP 4A1 protein expression and CYP 4A activity were minimized by the CYP 4A inhibitor, aminobenzotriazole (50 mg/kg, i.p. 1 h after endotoxin). These data suggest that prostaglandins produced during endotoxemia increase iNOS protein expression and NO synthesis, and decrease CYP 4A protein expression and CYP 4A activity and that inhibition of iNOS or COX restores renal CYP 4A protein level and CYP 4A activity and MAP presumably due to increased production of arachidonic acid metabolites derived from CYP 4A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704327      PMCID: PMC2684946          DOI: 10.1007/s12272-001-1238-x

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  56 in total

Review 1.  Comparative aspects of the mammalian cytochrome P450 IV gene family.

Authors:  G G Gibson
Journal:  Xenobiotica       Date:  1989-10       Impact factor: 1.908

Review 2.  Chronic nitric oxide inhibition model six years on.

Authors:  R Zatz; C Baylis
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

3.  Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.

Authors:  K W Renton; T E Nicholson
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

4.  Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule.

Authors:  Bruno A Escalante; John C McGiff; Adebayo O Oyekan
Journal:  Am J Physiol Renal Physiol       Date:  2002-01

5.  Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride.

Authors:  A O Oyekan; T Youseff; D Fulton; J Quilley; J C McGiff
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

6.  Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia.

Authors:  S R Mitchell; M B Sewer; S S Kardar; E T Morgan
Journal:  Drug Metab Dispos       Date:  2001-01       Impact factor: 3.922

7.  Nitric oxide activates cyclooxygenase enzymes.

Authors:  D Salvemini; T P Misko; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries.

Authors:  M Alonso-Galicia; C W Sun; J R Falck; D R Harder; R J Roman
Journal:  Am J Physiol       Date:  1998-09

9.  The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase.

Authors:  A R Amin; P Vyas; M Attur; J Leszczynska-Piziak; I R Patel; G Weissmann; S B Abramson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs.

Authors:  E Rekka; E O Ayalogu; D F Lewis; G G Gibson; C Ioannides
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

View more
  8 in total

1.  Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock.

Authors:  Bahar Tunctan; Sefika P Kucukkavruk; Meryem Temiz-Resitoglu; Demet S Guden; Ayse N Sari; Seyhan Sahan-Firat
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

2.  NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite.

Authors:  Bahar Tunctan; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; C Kemal Buharalioglu; Seyhan Sahan-Firat; Belma Korkmaz; John R Falck; Kafait U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-09-05       Impact factor: 3.072

3.  Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide.

Authors:  C Kemal Buharalioglu; Belma Korkmaz; Tuba Cuez; Seyhan Sahan-Firat; Ayse Nihal Sari; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-05-06       Impact factor: 4.080

4.  Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats.

Authors:  Bahar Tunctan; Belma Korkmaz; Tuba Cuez; C Kemal Buharalioglu; Seyhan Sahan-Firat; John Falck; Kafait U Malik
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-11       Impact factor: 4.080

5.  A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats.

Authors:  Tuba Cuez; Belma Korkmaz; C Kemal Buharalioglu; Seyhan Sahan-Firat; John Falck; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-07       Impact factor: 4.080

6.  Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production.

Authors:  Bahar Tunctan; Fariborz A Yaghini; Anne Estes; Kafait U Malik
Journal:  Arch Pharm Res       Date:  2008-08-14       Impact factor: 4.946

7.  Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.

Authors:  Bahar Tunctan; Belma Korkmaz; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; Mehmet Sami Serin; C Kemal Buharalioglu; Seyhan Sahan-Firat; Tuba Cuez; Wolf-Hagen Schunck; Vijaya L Manthati; John R Falck; Kafait U Malik
Journal:  Nitric Oxide       Date:  2013-05-14       Impact factor: 4.427

8.  A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats.

Authors:  Bahar Tunctan; Belma Korkmaz; C Kemal Buharalioglu; Seyhan Sahan Firat; Siddam Anjaiah; John Falck; Richard J Roman; Kafait U Malik
Journal:  Shock       Date:  2008-09       Impact factor: 3.454

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.